Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.

Abstract

Case B complements Case A, describing pharmaceutical companies' strategic responses-such as mega-mergers and acquisitions and specialization-to industry-wide global challenges and highlights strategic decisions by Pfizer's chief executive officers between 2007 and 2018.
Location:
Size:
Large
Other setting(s):
2018

About

Abstract

Case B complements Case A, describing pharmaceutical companies' strategic responses-such as mega-mergers and acquisitions and specialization-to industry-wide global challenges and highlights strategic decisions by Pfizer's chief executive officers between 2007 and 2018.

Settings

Location:
Size:
Large
Other setting(s):
2018

Related